CLINICAL_TRIALS
trial_result
· 2016-06-22
Clinical Trial Update: A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) [Phase 1]
Summary
Phase 1 pharmacokinetic study evaluating single-dose Vibegron (MK-4618) in adults with hepatic insufficiency completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Overactive Bladder | Phase 1 | Status: COMPLETED | Results posted: 2016-06-22